A German trial found that a minimally invasive tricuspid valve repair cut the risk of death or heart failure hospitalization by roughly 60 percent over three years in high-risk patients, resolving a question that had lingered since earlier trials.
A nurse-coordinated care model tested in 1,507 patients across 22 Indian hospitals cut heart failure deaths by 22 percent over two years, addressing one of cardiology's most persistent gaps: patients not receiving medications proven to save lives.
